| GEBR‐7b, a novel PDE4D selective inhibitor that improves memory in rodents at non‐emetic doses O Bruno, E Fedele, J Prickaerts, LA Parker, E Canepa, C Brullo, ... British journal of pharmacology 164 (8), 2054-2063, 2011 | 144 | 2011 |
| Cholesterol and Alzheimer's disease: a still poorly understood correlation R Ricciarelli, E Canepa, B Marengo, UM Marinari, G Poli, MA Pronzato, ... IUBMB life 64 (12), 931-935, 2012 | 62 | 2012 |
| Modulation of cAMP levels by high‐fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression JM Zingg, ST Hasan, K Nakagawa, E Canepa, R Ricciarelli, L Villacorta, ... Biofactors 43 (1), 42-53, 2017 | 47 | 2017 |
| Cholesterol and amyloid-β: evidence for a cross-talk between astrocytes and neuronal cells E Canepa, R Borghi, J Viña, N Traverso, J Gambini, C Domenicotti, ... Journal of Alzheimer's Disease 25 (4), 645-653, 2011 | 46 | 2011 |
| p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment B Marengo, CG De Ciucis, R Ricciarelli, AL Furfaro, R Colla, E Canepa, ... Cell death & disease 4 (4), e589-e589, 2013 | 39 | 2013 |
| Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer’s disease and stroke N Lemon, E Canepa, MA Ilies, S Fossati Frontiers in aging neuroscience 13, 772278, 2021 | 36 | 2021 |
| Impact of tau on neurovascular pathology in Alzheimer's disease E Canepa, S Fossati Frontiers in neurology 11, 573324, 2021 | 36 | 2021 |
| A novel mechanism for cyclic adenosine monophosphate–mediated memory formation: Role of amyloid beta R Ricciarelli, D Puzzo, O Bruno, E Canepa, E Gardella, D Rivera, ... Annals of Neurology 75 (4), 602-607, 2014 | 36 | 2014 |
| Endothelial activation of caspase-9 promotes neurovascular injury in retinal vein occlusion MI Avrutsky, C Colón Ortiz, KV Johnson, AM Potenski, CW Chen, ... Nat Commun, 2020 | 29 | 2020 |
| Cyclic adenosine monophosphate as an endogenous modulator of the amyloid‐β precursor protein metabolism E Canepa, C Domenicotti, B Marengo, M Passalacqua, UM Marinari, ... IUBMB life 65 (2), 127-133, 2013 | 29 | 2013 |
| FDA‐approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness E Canepa, R Parodi‐Rullan, R Vazquez‐Torres, B Gamallo‐Lana, ... Alzheimer's & Dementia 19 (11), 5048-5073, 2023 | 8 | 2023 |
| Amyloid Beta Oligomers Activate Death Receptors and Mitochondria-Mediated Apoptotic Pathways in Cerebral Vascular Smooth Muscle Cells; Protective Effects of Carbonic Anhydrase … A Anzovino, E Canepa, M Alves, NL Lemon, RO Carare, S Fossati Cells 12 (24), 2840, 2023 | 1 | 2023 |
| Carbonic anhydrase inhibition ameliorates Aβ‐induced neurovascular dysfunction in vivo Molecular and cell biology/vascular factors E Canepa, R Vazquez‐Torres, L Debure, S Fossati Alzheimer's & Dementia 16, e044221, 2020 | 1 | 2020 |
| Homocysteine potentiates amyloid β\upbeta‐induced death receptor 4‐and 5‐mediated cerebral endothelial cell apoptosis, blood brain barrier dysfunction and angiogenic impairment A Carey, R Parodi‐Rullan, R Vazquez‐Torres, E Canepa, S Fossati Aging Cell, e14106, 2024 | | 2024 |
| FDA-approved carbonic anhydrase inhibitors reduce amyloid beta pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness (vol 19, pg 5048, 2023) E Canepa, R Parodi-Rullan, R Vazquez-Torres ALZHEIMERS & DEMENTIA, 2024 | | 2024 |
| Correction to “FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness” E Canepa, R Parodi-Rullan, R Vazquez-Torres | | 2024 |
| FDA‐approved carbonic anhydrase inhibitors rescue brain Aβ overload, cerebrovascular pathology and gliosis in Alzheimer’s disease model E Canepa, R Vazquez‐Torres, RA Guzman‐Hernandez, L Debure, ... Alzheimer's & Dementia 19, e078985, 2023 | | 2023 |
| HOMOCYSTEINE POTENTIATES AMYLOID β-INDUCED CEREBRAL ENDOTHELIAL CELL APOPTOSIS, BLOOD BRAIN BARRIER DYSFUNCTION AND ANGIOGENIC IMPAIRMENT AM Carey, R Parodi, R Vazquez, E Canepa, S Fossati bioRxiv, 2023.07. 06.547994, 2023 | | 2023 |
| Carbonic anhydrase inhibitors: a novel pharmacological strategy to rescue Aβ‐induced neurovascular pathology and gliosis in vivo E Canepa, R Vazquez‐Torres, R Guzman‐Hernandez, L Debure, ... Alzheimer's & Dementia 18, e064284, 2022 | | 2022 |
| Pharmacological inhibition of carbonic anhydrases ameliorates cognitive dysfunction, rescuing Aβ‐induced neurovascular pathology in vivo E Canepa, R Vazquez‐Torres, RM Parodi‐Rullan, F Angiulli, L Debure, ... Alzheimer's & Dementia 17, e054199, 2021 | | 2021 |
Umberto MarinariProfessore Emerito, Department of Experimental Medicine, University of GenoaVerified email at unige.it
